European society of medical oncology (ESMO) 2019 meeting report features practice changing data in gynecologic malignancies.
Publication
, Journal Article
Herzog, TJ; Secord, AA; Coleman, RL; Naumann, RW
Published in: Gynecol Oncol
February 2020
Multiple practice changing studies were presented at the 2019 ESMO Congress in Barcelona, Spain. The ovarian cancer studies presented at the Presidential session will likely refine and redefine the initial treatment of ovarian cancer. Other compelling trial data in ovarian, uterine and cervical cancer were also unveiled. The key oral abstracts from this meeting are summarized in this meeting report.
Duke Scholars
Published In
Gynecol Oncol
DOI
EISSN
1095-6859
Publication Date
February 2020
Volume
156
Issue
2
Start / End Page
265 / 270
Location
United States
Related Subject Headings
- Randomized Controlled Trials as Topic
- Oncology & Carcinogenesis
- Humans
- Genital Neoplasms, Female
- Female
- Clinical Trials, Phase III as Topic
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Herzog, T. J., Secord, A. A., Coleman, R. L., & Naumann, R. W. (2020). European society of medical oncology (ESMO) 2019 meeting report features practice changing data in gynecologic malignancies. Gynecol Oncol, 156(2), 265–270. https://doi.org/10.1016/j.ygyno.2019.11.010
Herzog, Thomas J., Angeles Alvarez Secord, Robert L. Coleman, and R Wendel Naumann. “European society of medical oncology (ESMO) 2019 meeting report features practice changing data in gynecologic malignancies.” Gynecol Oncol 156, no. 2 (February 2020): 265–70. https://doi.org/10.1016/j.ygyno.2019.11.010.
Herzog TJ, Secord AA, Coleman RL, Naumann RW. European society of medical oncology (ESMO) 2019 meeting report features practice changing data in gynecologic malignancies. Gynecol Oncol. 2020 Feb;156(2):265–70.
Herzog, Thomas J., et al. “European society of medical oncology (ESMO) 2019 meeting report features practice changing data in gynecologic malignancies.” Gynecol Oncol, vol. 156, no. 2, Feb. 2020, pp. 265–70. Pubmed, doi:10.1016/j.ygyno.2019.11.010.
Herzog TJ, Secord AA, Coleman RL, Naumann RW. European society of medical oncology (ESMO) 2019 meeting report features practice changing data in gynecologic malignancies. Gynecol Oncol. 2020 Feb;156(2):265–270.
Published In
Gynecol Oncol
DOI
EISSN
1095-6859
Publication Date
February 2020
Volume
156
Issue
2
Start / End Page
265 / 270
Location
United States
Related Subject Headings
- Randomized Controlled Trials as Topic
- Oncology & Carcinogenesis
- Humans
- Genital Neoplasms, Female
- Female
- Clinical Trials, Phase III as Topic
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis